Psychedelics Today Podcast
710 episodes
A show discussing the important academic and other research in the field of psychedelics, and how it relates to human potential and healing.
PT357 – Dr. Hans Eriksson – Precision Psychiatry, Ketabon, and The Stress Response System
Sep, 20, 2022
In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule. www.psychedelicstoday.com
PT356 – Brom Rector – Investing in Psychedelics and The Rush to Improve on the Classics
Sep, 16, 2022
In this episode, Joe interviews Brom Rector: podcaster and founder of Empath Ventures, a venture capital fund that invests in psychedelic medicine startups. They discuss investment, IP, the psychedelic crash, ibogaine, and more. www.psychedelicstoday.com
Psychedelics
PT355 – Ifetayo Harvey – The Drug War, Caregiving, and Blue Sky Thinking
Sep, 13, 2022
In this episode, David interviews Founder of the People of Color Psychedelic Collective: Ifetayo Harvey. She talks about the racism of the drug war, the importance of caregiving, and what we can do collectively to make change. www.psychedelicstoday.com
PT354 – Laura Guzmán-Dávalos – Psilocybe, Microdosing, and Multigenerational Mycology
Sep, 09, 2022
In this episode, Joe interviews Laura Guzmán-Dávalos: 40-year veteran mycologist at the University of Guadalajara, Mexico; and daughter of Gaston Guzman, who most consider the world authority on the genus, Psilocybe. www.psychedelicstoday.com
PT353 – Dr. James Fadiman, Dr. Sam Gandy, & Dr. David Luke – Psychedelics and Creativity
Sep, 06, 2022
In this episode, Kyle interviews Doctors James Fadiman, Sam Gandy; and David Luke. They discuss Fadiman's past research and Gandy and Luke's new paper, "Psychedelics as potential catalysts of scientific creativity and insight." www.psychedelicstoday.com
Psychedelics
PT352 – Alex Enchin & Ian-Michael Hébert, MA – HOLOS: Returning to Wholeness Through Nature and Community
Sep, 02, 2022
In this episode, Joe interviews Alex Enchin & Ian-Michael Hébert, MA; Co-Founders of HOLOS, a company building hospitality wellness centers with a strong focus on community, reconnection to nature, and a return to wholeness. www.psychedelicstoday.com
PT351 – Seth Rosenberg – The Trauma In Being Arrested and The Injustice of the Drug War
Aug, 30, 2022
In this episode, Joe interviews Seth Rosenberg: Washington DC-based mycologist and anti-drug war advocate who worked on DC's decriminalization Initiative 81, and who was presumably arrested for purchasing legal plants online. www.psychedelicstoday.com
PT350 – Jim Gilligan – Psilocybin and Accessing the “Off” Switch For Nociplastic Pain
Aug, 26, 2022
In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain. www.psychedelicstoday.com
Psilocybin
PT349 – Brenna Gebauer – Slowing Down, The Ethics of Touch, and The Value of Preparation
Aug, 23, 2022
In this episode, Joe interviews transformational coach and guide, Brenna Gebauer; in-person from her parents' RV at this year's Lightning in a Bottle festival, with facilitator and past guest, Mark Haberstroh stopping in too. www.psychedelicstoday.com
PT348 – Steve DeAngelo – Cannabis and Psychedelics: Industry, Consciousness, Justice, and Joy
Aug, 19, 2022
In this episode, David interviews globally-recognized cannabis activist, author, entrepreneur, speaker, podcaster, and “Father of the Legal Cannabis Industry,” Steve DeAngelo; discussing industry, decriminalization, and more! www.psychedelicstoday.com
Cannabis
PT347 – Christopher Koddermann – Rescheduling Psilocybin, Patents and IP, and The Entourage Effect
Aug, 16, 2022
In this episode, Joe interviews Christopher Koddermann: Co-Founder of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI). He discusses patents, IP, and what needs to be done to reschedule psilocybin. www.psychedelicstoday.com
Psilocybin
PT346 – Kevin Balktick – Horizons Northwest, The Psilocybin Services Act, and the Power of Gathering Together
Aug, 12, 2022
In this episode, David interviews Kevin Balktick: Founder & Director of Horizons; one of the world's longest-running psychedelic media and education communities, which is expanding to Portland, Oregon this year with Horizons NW. www.psychedelicstoday.com
Psilocybin
PT345 – Steve Thayer, Ph.D. – Vital Psychedelic Conversations
Aug, 09, 2022
In this episode, "Vital Psychedelic Conversations" returns with Kyle interviewing Steve Thayer: psychologist, Clinical Director of Education & Training at Novamind, and co-host of the Psychedelic Therapy Frontiers podcast. www.psychedelicstoday.com
PT344 – Susan Beaulieu – Epigenetics, Resilience, and Remembering
Aug, 05, 2022
In this episode, David interviews Susan Beaulieu: Extension Educator at the University of Minnesota Extension, who works with her community (the Anishinaabe people) around intergenerational trauma and community resilience. www.psychedelicstoday.com
PT343 – Soren Shade – Kratom and Anti-Prohibition: Lessons Learned and Applied
Aug, 02, 2022
In this episode, Joe interviews Soren Shade: producer of the third season of “Hamilton’s Pharmacopeia" and Co-Founder of Top Tree Herbs, a kratom tea company dedicated to educating people about kratom and normalizing its use. www.psychedelicstoday.com
PT342 – Spencer Hawkswell – The Right to Psilocybin in Canada: TheraPsil’s Charter Challenge
Jul, 29, 2022
In this episode, Victoria Dekker debuts, interviewing the CEO of TheraPsil, Spencer Hawkswell, about the charter challenge that effectively sues the Canadian government for ending psilocybin exemptions for end-of-life patients. www.psychedelicstoday.com
Psilocybin
PT341 – Monnica Williams, Ph.D. – Racism, Trauma, Research, and Psychedelics
Jul, 26, 2022
In this episode, David interviews Monnica Williams, Ph.D. She discusses the mental health impact communities of color face as a result of racism; and what therapists, clinicians, and researchers can do to improve this paradigm. www.psychedelicstoday.com
Psychedelics
PT341 – Monnica Williams, Ph.D. – Racism, Trauma, Research, and Psychedelics
Jul, 26, 2022
In this episode, David interviews Monnica Williams, Ph.D. She discusses the mental health impact communities of color face as a result of racism; and what therapists, clinicians, and researchers can do to improve this paradigm. www.psychedelicstoday.com
Psychedelics
PT341 – Monnica Williams, Ph.D. – Racism, Trauma, Research, and Psychedelics
Jul, 26, 2022
In this episode, David interviews Monnica Williams, Ph.D. She discusses the mental health impact communities of color face as a result of racism; and what therapists, clinicians, and researchers can do to improve this paradigm. www.psychedelicstoday.com
Psychedelics
PT340 – Joost Breeksema – The Interdisciplinary Conference on Psychedelic Research (ICPR) & The Patient Perspective
Jul, 22, 2022
In this episode, David interviews Joost Breeksema: Executive Director of the OPEN Foundation, which manages the Interdisciplinary Conference on Psychedelic Research (ICPR) which returns to Amsterdam this September 21-24. www.psychedelicstoday.com